Plenary session 4 — screening for cervical cancer precursors
Spontaneous evolution of intraepithelial lesions according to the grade and type of the implicated human papillomavirus (HPV)

https://doi.org/10.1016/0028-2243(95)02303-AGet rights and content

Abstract

Because of the fact that any meaningful classification should bear a close relationship to the biological behavior of the lesions, the usefulness of all new classifications of cervical precancer lesions can only be established by well controlled prospective follow-up studies. However, several methodological and conceptual problems are encountered in the natural history studies conducted during the past several decades. While reviewing the available prospective follow-up studies on cervical intraepithelial neoplasia (CIN), Östör (1993) found 3529 cases of CIN 1, of which 57% showed regression, persistence was found in 32%, progression to CIN III in 11%, and progression to invasive cancer in 1% of cases. The corresponding figures for CIN II were 43%, 35%, 22%, and 5%, respectively. The recognition of the association between human papillomavirus (HPV) and CIN has further complicated the assessment of the natural history of cervical precancer lesions. Results from the early prospective follow-up studies are remarkably consistent, however. Progression from HPV-NCIN (i.e., koilocytosis without CIN) to CIN I or greater was reported for 18 (8%) of 232 women followed by Syrjänen et al. for an average of 25 months, for 26 (8%) of 314 women followed by de Brux et al. (1981) for 15 to 18 months, and for 113 (13%) of 846 women followed for up to six years by Mitchell et al. During a 42-month follow-up period, 10% progression rate was found in 1269 women with HPV-CIN I, and in 17% of 762 women with HPV-CIN II by de Brux et al. (1983). The spontaneous regression rates were 53% and 39% in these cohorts, respectively. This is fully consonant with our experience from an almost 14-year follow-up of 530 women in Kuopio, where the spontaneous regression rate seems to increase in parallel with the extent of the follow-up time, currently being 66.7% for HPV-NCIN and 55.7% for HPV-CIN I. The figures for progression are 6.3% and 14.2%, respectively. It is obvious that the probability of a cervical precancer lesion to progress into an invasive disease increases with the severity of the atypia. Another distinct prognostic factor is HPV type, HPV 16 lesions possessing a significantly higher risk for progression than infections by other HPV types. The follow-up data also indicate, however, that even the high grade lesions may spontaneously regress, which should have important implications in therapy. The continuous problem still remains; these natural history observations only apply to a large series of women but are of little help in predicting the disease outcome in individual women.

References (98)

  • BS Hulka

    Cytological and histologie outcome following an atypical cervical smear

    Am J Obstet Gynecol

    (1968)
  • B Peckham et al.

    Follow-up on cervical epithelial abnormalities

    Am J Obstet Gynecol

    (1957)
  • D Hellberg et al.

    Positive cervical smear with subsequent normal colposcopy and histology — frequency of CIN in a long-term follow-up

    Gynecol Oncol

    (1994)
  • GP Downey et al.

    Relation between human papilloma-virus type 16 and potential for progression of minor-grade cervical disease

    Lancet

    (1994)
  • P Kenemans

    HPV genotype as a prognostic factor for progression to cervical carcinoma in young women

    Eur J Obstet Gynecol Reprod Biol

    (1994)
  • G Terry et al.

    Relation between human papillomavirus type 16 and potential for progression of minorgrade cervical disease

    Lancet

    (1994)
  • J Schottländer et al.
  • G Riotton et al.
    (1973)
  • RM Richart

    Cervical intraepithelial neoplasia

    Pathol Ann

    (1973)
  • National Cancer Institute Workshop

    The 1988 Bethesda system for reporting cervical/vaginal cytological diagnoses

    JAMA

    (1989)
  • AG Östor

    Natural history of cervical intraepithelial neoplasia — a critical review

    Int J Gynecol Pathol

    (1993)
  • K Syrjänen et al.

    Prevalence of genital human papillomavirus infections in a mass-screened Finnish female population aged 20–65 years

    Int J STD AIDS

    (1990)
  • K Syrjänen et al.

    Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population

    Sex Transm Dis

    (1990)
  • B Fredricsson et al.

    Is there a changing epidemiology of premalignant lesions of the cervix

    Acta Obstet Gynecol Scand

    (1977)
  • LA Koutsky et al.

    Epidemiology of genital human papillomavirus infection

    Epidemiol Rev

    (1988)
  • M Bibbo et al.

    DNA ploidy profiles as prognostic indicators in CIN lesions

    Am J Clin Pathol

    (1989)
  • MA Byrne et al.

    A prospective study of human papillomavirus infection of the cervix

    Cytopathology

    (1990)
  • K Nasiell et al.

    Behavior of mild cervical dysplasia during long term follow up

    Obstet Gynecol

    (1986)
  • K Nasiell et al.

    Behavior of moderate cervical dysplasia during long term follow up

    Obstet Gynecol

    (1983)
  • E Stern et al.

    Dysplasia of the uterine cervix incidence of regression reccurrence and cancer

    Cancer

    (1964)
  • SJ Sondheimer et al.

    Mild cervical dysplasia experience in a family planning clinic

    J Reprod Med

    (1983)
  • K Syrjänen

    Epidemiology of human papillomavirus (HPV) infections and their associations with genital squamous cell cancer (Review article)

    APMIS

    (1989)
  • KJ Syrjänen

    Natural history of genital HPV infections

    Papillomavirus Rep

    (1990)
  • HJ Kwikkel et al.

    Stolk. Relation of quantitative features of visually normal intermediate cells in cervical intraepithelial neoplasia I, II

    Anal Quant Cytol Histol

    (1987)
  • K Syrjänen et al.

    Natural history of cervical human papillomavirus (HPV) infections based on prospective followup

    Br J Obstet Gynaecol

    (1985)
  • K Syrjänen et al.

    Factors associated with the clinical behaviour of cervical human papillomavirus infections during a long term prospctive follow up

    Cervix

    (1989)
  • E Burghardt et al.

    Colposcopy, cervical pathology

  • AR Chang

    Carcinoma in situ of the cervix and its malignant potential. A lesson from New Zealand

    Cytopathol

    (1990)
  • V Kataja et al.

    Prospective follow-up of cervical HPV infections: life table analysis of histopathological, cytological and colposcopic data

    Eur J Epidemiol

    (1989)
  • V Kataja et al.

    Prospective follow-up of genital HPV infections: survival analysis of the HPV typing data

    Eur J Epidemiol

    (1990)
  • V Kataja et al.

    Prognostic factors in cervical human papillomavirus infections

    Sex Transm Dis

    (1992)
  • KJ Syrjänen

    Genital Human papillomavirus (HPV) infections and their associations with squamous cell cancer: Reapprisal of the morphologic, epidemiologic and DNA data

  • KJ Syrjänen

    Current Concepts of Human papillomavirus infections in the genital tract and their relationship to intraepithelial neoplasia and squamous cell carcinoma

    Obstet Gynecol Surv

    (1984)
  • K Syrjänen

    Human papillomavirus (HPV) infections of the female genital tract and their associations with intraepithelial neoplasia and squamous cell carcinoma

    Pathol Annu

    (1986)
  • KJ Syrjänen

    Papillomaviruses and Cancer

  • CH Fox

    Biologic behavior of dysplasia and carxinoma in situ

    Am J Obstet Gynecol

    (1967)
  • AI Spriggs

    Natural history of cervical dysplasia

    Clin Obstet Gynaecol

    (1981)
  • U Villa Santa

    Diagnosis and prognosis of cervical dysplasia

    Obstet Gynecol

    (1971)
  • Cited by (96)

    • Fluorescence microscopy of H&E stained cervical biopsies to assist the diagnosis and grading of CIN

      2018, Pathology Research and Practice
      Citation Excerpt :

      In addition to not being able to always predict the biologic behavior of CIN lesions, the histopathological classification of cervical biopsies is problematic. This occurs because the criteria for CIN diagnosis is subjective and has high inter and intra-observer variability [18,19]. A study by Stoler et al. showed that the concordance rate of diagnosing CIN1 was 38.2% between community pathologists and an expert panel of gynecological pathologists, while rate for CIN2 was 38% and CIN3 68% [20].

    • Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: Potential additional benefit of a nine-valent second generation HPV vaccine compared to first generation HPV vaccines

      2015, Papillomavirus Research
      Citation Excerpt :

      By extrapolating these data to countries without or with less organized screening, we overestimated the detected burden in those countries. However these lesions do exist, even if not detected, and have a high potential to develop to cancer if not recognized and treated: 5% of CIN2 and more than 12% of CIN3 progress to invasive cancer [29]. Mc Credie et al. found that the cumulative 30 year incidence of invasive cancer in women with CIN3 was 30% and increased to 50% in women with persistent CIN3 [30].

    • SOX1 suppresses cell growth and invasion in cervical cancer

      2013, Gynecologic Oncology
      Citation Excerpt :

      The E6 and E7 oncoproteins, encoded in high-risk HPV types, inactivate p53 and retinoblastoma (Rb) proteins and cause abnormal transformation [3]. However, HPV infection is necessary but is not enough to cause cervical cancer [4], and the molecular mechanisms underlying cervical carcinogenesis remain elusive. Genetic changes and epigenetic changes play important roles in the complex signaling pathways involved in cervical cancer development [5–10].

    View all citing articles on Scopus
    View full text